AMA to help FDA develop patient information on meds

Article Abstract:

The Food and Drug Administration (FDA)'s planned patient education program on the correct use of prescribed drugs will be tempered by the participation of the American Medical Association, designed to prevent unnecessary federal intrusion into doctor-patient relationships. The program will set standards and goals to improve the quality and dissemination of information on prescribed drugs. A survey by the FDA found that 55% of patients received substantial written information on drugs in 1994, as compared to 23% in 1992, but that information quality varied.

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Product Safety-Drugs & Cosmetics, Planning, Drugs, Information services, American Medical Association, Product safety, Pharmacy, Patient education, United States. Food and Drug Administration

---

Replacement parts

Article Abstract:

The use of manufactured devices to replace faulty internal organs is rising, along with concerns over liability and safety. Almost one in 17 individuals in industrialized nations has a medical implant, and physicians must be able to identify them to prevent treatments that may damage the implants and harm the patients. Another problem is lack of biomaterials due to liability claims, which has slowed research and advancement in the medical implant field.

Surgical Appliance and Supplies Manufacturing, Surgical appliances and supplies, Artificial Organs, Usage, Product development, Medical equipment industry, Materials, Biomedical materials, Biomaterials, Surgical equipment and supplies industry

---

Medical concerns linger for 'fountain of youth' hormone

Article Abstract:

Dehydroepiandrosterone, or DHEA, is a natural hormone produced by the adrenal glands. Experiments show that it heightens mood and increases vitality, but daily doses of 50 mg or more may produce syptoms including facil hair in women plus acne and irritability. Although the substance can be purchased as a dietary supplement, knowledgeable physicians discourage its use, since nothing is known about possible long-term effects.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Hormone Preparations, Physiological aspects, Hormones, Dehydroepiandrosterone

Similar abstracts:

• Abstracts: An economic evaluation of asthma in the United States. Tetanus - forgotten but not gone. A population-based serologic survey of immunity to tetanus in the United States
• Abstracts: Swansong for free degrees: what are the implications of the Dearing report for nursing students? Practice makes perfect
• Abstracts: Findings on host resistance genes for infectious diseases are pointing the way to drugs, vaccines. Fighting infectious disease threats via research: a talk with Anthony S. Fauci
• Abstracts: Parting shots. The Overseas Development Agenda and occupational safety and health. Selling safety
• Abstracts: Altered thyroid function in nonthyroidal illness and surgery: to treat or not to treat? Insulin and the polycystic ovary syndrome

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.